Floatz logo

Therapeutic Asset Ratings

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Diphenhydramine
Neoplasm
Hellenic Society of HematologyP2BBB (72)
Everolimus
Neoplasm
Uppsala University HospitalP2BBB (72)
Immunoglobulin G1, Anti-(Human Vascular Endothelial Growth Factor Receptor Type Vegfr-2 Extracellular Domain) (Human Monoclonal Imc-1121B .Gamma.-Chain), Disulphide With Human Monoclonal Imc-1121B .Kappa.-Chain, Dimer
Cancer
Eli Lilly and CompanyP2BBB (72)
Immunoglobulin G1, Anti-(Human Vascular Endothelial Growth Factor Receptor Type Vegfr-2 Extracellular Domain) (Human Monoclonal Imc-1121B .Gamma.-Chain), Disulphide With Human Monoclonal Imc-1121B .Kappa.-Chain, Dimer
Renal Cell Carcinoma
Novartis PharmaceuticalsP2BBB (72)
Irinotecan
Pancreatic Acinar Cell Carcinoma
Artios Pharma LtdP2BBB (72)
Melphalan
Acute Leukemia
Center for International Blood and Marrow Transplant ResearchP2BBB (72)
Melphalan
Plasma Cell Leukemia
National Cancer Institute (NCI)P2BBB (72)
Melphalan
B-Cell Chronic Lymphocytic Leukemia
H. Lee Moffitt Cancer Center and Research InstituteP2BBB (72)
Mesna
Acute Myeloid Leukemia
Center for International Blood and Marrow Transplant ResearchP2BBB (72)
Mesna
Myelodysplastic Syndrome
Center for International Blood and Marrow Transplant ResearchP2BBB (72)
Nivolumab
Castration-Resistant Prostate Carcinoma
Rana McKay, MDP2BBB (72)
Nivolumab
Colorectal Adenocarcinoma
University Hospital, AkershusP2BBB (72)
Nivolumab
Colorectal Carcinoma
Fred Hutchinson Cancer CenterP2BBB (72)
Nivolumab
Lymphoma
National Cancer Institute (NCI)P2BBB (72)
Nivolumab
Peripheral T-Cell Lymphoma, Not Otherwise Specified
University of Michigan Rogel Cancer CenterP2BBB (72)
Oxaliplatin
B-Cell Non-Hodgkin Lymphoma
Mwanasha Merrill, MDP2BBB (72)
Pembrolizumab
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Roswell Park Cancer InstituteP2BBB (72)
Pembrolizumab
Estrogen-Receptor Negative Breast Cancer
Massachusetts General HospitalP2BBB (72)
Pembrolizumab
Marginal Zone Lymphoma
University of UlmP2BBB (72)
Pembrolizumab
Mycosis Fungoides
Sorrento Therapeutics, Inc.P2BBB (72)
Pembrolizumab
Pancreatic Adenocarcinoma
Mayo ClinicP2BBB (72)
Pembrolizumab
Progesterone-Receptor Negative Breast Cancer
Massachusetts General HospitalP2BBB (72)
Pembrolizumab
Metastatic Prostate Carcinoma
CuraCell TX ABP2BBB (72)
Pembrolizumab
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Mayo ClinicP2BBB (72)
Pembrolizumab
Sarcoma
Essen BiotechP2BBB (72)
Showing 2776 to 2800 of 42,289 assets
PreviousPage 112 of 1692Next